125 related articles for article (PubMed ID: 1754895)
1. Etidronate sodium therapy--a cause of poor skeletal radiopharmaceutical uptake.
DeMeo JH; Balseiro J; Cole TJ
Semin Nucl Med; 1991 Oct; 21(4):332-4. PubMed ID: 1754895
[No Abstract] [Full Text] [Related]
2. Duration of etidronate effect demonstrated by serial bone scintigraphy.
Sandler ED; Parisi MT; Hattner RS
J Nucl Med; 1991 Sep; 32(9):1782-4. PubMed ID: 1908891
[TBL] [Abstract][Full Text] [Related]
3. Case report: intravenous etidronate as a cause of poor uptake on bone scanning, with a review of the literature.
Chong WK; Cunningham DA
Clin Radiol; 1991 Oct; 44(4):268-70. PubMed ID: 1835685
[TBL] [Abstract][Full Text] [Related]
4. Skeletal nonvisualization in a bone scan secondary to intravenous etidronate therapy.
Hommeyer SH; Varney DM; Eary JF
J Nucl Med; 1992 May; 33(5):748-50. PubMed ID: 1569485
[TBL] [Abstract][Full Text] [Related]
5. Etidronate therapy decreases the sensitivity of bone scanning with methylene diphosphonate labelled with technetium-99m.
Murphy KJ; Line BR; Malfetano J
Can Assoc Radiol J; 1997 Jun; 48(3):199-202. PubMed ID: 9193420
[TBL] [Abstract][Full Text] [Related]
6. Cyclical etidronate treatment of osteoporosis.
N Engl J Med; 1990 Dec; 323(23):1633-5. PubMed ID: 2122254
[No Abstract] [Full Text] [Related]
7. False-negative bone imaging due to etidronate disodium therapy.
Krasnow AZ; Collier BD; Isitman AT; Hellman RS; Ewey D
Clin Nucl Med; 1988 Apr; 13(4):264-7. PubMed ID: 3131057
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m-methylene disphosphonate (MDP) bone scan hypercalcemia.
Basoglu T; Canbaz F; Bernay I
J Nucl Med; 1998 Dec; 39(12):2034, 5A. PubMed ID: 9867137
[No Abstract] [Full Text] [Related]
9. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
10. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
11. Bone scintigraphy in evaluation of Didronel therapy for Paget's disease.
Lee JY
Clin Nucl Med; 1981 Aug; 6(8):356-8. PubMed ID: 6455232
[TBL] [Abstract][Full Text] [Related]
12. What do we want from a bone-scanning agent?
Fogelman I; Bessent RG
J Nucl Med; 1980 Mar; 21(3):296. PubMed ID: 6445001
[No Abstract] [Full Text] [Related]
13. The bisphosphonate dilemma.
Koyano H; Schimizu T; Shishiba Y
J Nucl Med; 1995 Apr; 36(4):705-6. PubMed ID: 7699469
[No Abstract] [Full Text] [Related]
14. New vistas on bone scintigraphy.
Nucl Med Commun; 1984 Jun; 5(6):359-60. PubMed ID: 6241663
[No Abstract] [Full Text] [Related]
15. Effects of intravenous etidronate disodium on skeletal and calcium metabolism.
Kanis JA; Urwin GH; Gray RE; Beneton MN; McCloskey EV; Hamdy NA; Murray SA
Am J Med; 1987 Feb; 82(2A):55-70. PubMed ID: 3103437
[TBL] [Abstract][Full Text] [Related]
16. Increased long-bone periosteal/cortical uptake in skeletal scintigraphy.
Kirshy DM; Dunn EK; Sarkar SD; Strashun AM
Semin Nucl Med; 1992 Jan; 22(1):54-7. PubMed ID: 1589809
[No Abstract] [Full Text] [Related]
17. Myocardial uptake of a bone tracer associated with hypercalcemia.
Atkins HL; Oster ZH
Clin Nucl Med; 1984 Nov; 9(11):613-5. PubMed ID: 6509834
[TBL] [Abstract][Full Text] [Related]
18. Radiation absorbed dose from technetium-99m-labeled bone imaging agents. Task Group of the Medical Internal Radiation Dose Committee, The Society of Nuclear Medicine.
Weber DA; Makler PT; Watson EE; Coffey JL; Thomas SR; London J
J Nucl Med; 1989 Jun; 30(6):1117-22. PubMed ID: 2544697
[No Abstract] [Full Text] [Related]
19. [Studies of the kinetics of bone concentration of mdp-tc 99m in Paget's disease and various treatment methods].
de La Rochefoucauld B; Basset JY; Rondier J; Cayla J; Ancri D
Rev Rhum Mal Osteoartic; 1984 Nov; 51(10):575-9. PubMed ID: 6241965
[TBL] [Abstract][Full Text] [Related]
20. Tc-99m MDP uptake in hepatoblastoma.
Elgazzar AH; Jahan S; Motawei S; Abdel-Dayem HM
Clin Nucl Med; 1989 Feb; 14(2):143. PubMed ID: 2543533
[No Abstract] [Full Text] [Related]
[Next] [New Search]
